Zobrazeno 1 - 10
of 728
pro vyhledávání: '"Timo E. Strandberg"'
Autor:
Piia Simonen, Lotta Nylund, Erkki Vartiainen, Petri T. Kovanen, Timo E. Strandberg, Katariina Öörni, Ingmar Wester, Helena Gylling
Publikováno v:
Lipids in Health and Disease, Vol 23, Iss 1, Pp 1-9 (2024)
Abstract The risk of atherosclerotic cardiovascular diseases (ASCVDs) can be reduced by lowering low-density lipoprotein cholesterol (LDL-C) concentrations. Nevertheless, ASCVDs still cause most deaths worldwide. Here, we discuss the prevention of AS
Externí odkaz:
https://doaj.org/article/4d389b17c55c43118e5037bd355caa8b
Autor:
Kaisu H. Pitkala, Laura Rautiainen, Ulla L. Aalto, Hannu Kautiainen, Annika Kolster, Marja-Liisa Laakkonen, Timo Partonen, Hanna-Maria Roitto, Timo E. Strandberg, Nerkez Opacin, Sibylle Puntscher, Uwe Siebert, Laura Coll-Planas, Ashby L. Sachs, Jill S. Litt, Anu H. Jansson, For the RECETAS project
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Loneliness is common among older adults in institutional settings. It leads to adverse effects on health and wellbeing, for which nature contact with peers in turn may have positive impact. However, the effects of nature engagemen
Externí odkaz:
https://doaj.org/article/07dd9a2f470f492eade9c4ee684733a9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Markus J. Haapanen, Timo Törmäkangas, Monika E. von Bonsdorff, Arto Y. Strandberg, Timo E. Strandberg, Mikaela B. von Bonsdorff
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Cardiovascular disease (CVD) is one of the leading causes of premature retirement. However, the relationship between CVD risk factors and workforce participation is not well known. We studied the relationship between midlife CVD risk, age at
Externí odkaz:
https://doaj.org/article/c6fc6f450be04663a0a158a3b08c0701
Publikováno v:
Journal of the American Geriatrics Society. 64(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ff40b943713c28bd22ab62feda38631
https://pubmed.ncbi.nlm.nih.gov/27459419
https://pubmed.ncbi.nlm.nih.gov/27459419
Autor:
Markus J. Haapanen, Timo E. Strandberg, Timo Törmäkangas, Monika E. von Bonsdorff, Arto Y. Strandberg, Mikaela B. von Bonsdorff
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Associations between retirement characteristics and consequent physical functioning (PF) are poorly understood, particularly in higher socioeconomic groups, where postponing retirement has had both positive and negative implicatio
Externí odkaz:
https://doaj.org/article/60f4dbcc213643eca6601189e8ea40ec
Autor:
Karri Kaivola, Matti Pirinen, Hannu Laaksovirta, Lilja Jansson, Osma Rautila, Jyrki Launes, Laura Hokkanen, Jari Lahti, Johan G. Eriksson, Timo E. Strandberg, FinnGen, Pentti J. Tienari
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
C9orf72 hexanucleotide repeat expansion is a common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). The C9orf72 locus may harbor residual risk outside the hexanucleotide repeat expansion, but the evidence is conflictin
Externí odkaz:
https://doaj.org/article/2e5229c504f94b7f82b772d45f2f0651
Publikováno v:
Atherosclerosis Plus, Vol 43, Iss , Pp 3-6 (2021)
SARS-CoV-2 infection continues to cause increased morbidity and mortality, and due to the slow pace of vaccination COVID-19 will probably remain a global burden to health systems for a long time. Unfortunately, the necessary prevention and treatment
Externí odkaz:
https://doaj.org/article/9088f025ab214926bd415ac4f84b58e5
Autor:
Michael A. Nauck, Darren K. McGuire, Karen S. Pieper, Yuliya Lokhnygina, Timo E. Strandberg, Axel Riefflin, Tuncay Delibasi, Eric D. Peterson, Harvey D. White, Russell Scott, Rury R. Holman
Publikováno v:
Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-10 (2019)
Abstract Background To examine the effects of the DPP-4i sitagliptin on CV outcomes during and after incident MI in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Methods TECOS randomized 14,671 participants with type 2 diabet
Externí odkaz:
https://doaj.org/article/f1b3ffca4f5a46b0a09a054de2bd029d
Autor:
Timo E Strandberg
Publikováno v:
The Lancet. Healthy Longevity, Vol 2, Iss 6, Pp e308-e309 (2021)
Externí odkaz:
https://doaj.org/article/4f46ef9e3bba4d4fbc5fe11ae0fe9a9e